US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 150.810
  • -1.120-0.74%
Close Mar 4 16:00 ET
  • 150.810
  • 0.0000.00%
Post 20:01 ET
9.03BMarket Cap-21.73P/E (TTM)

Ascendis Pharma A/S Key Stats

Ascendis Pharma A/S Q4 2024 Earnings Date

Currency:USDFeb 12, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
124.45M
180.98M
+56.53M
Beat Est.
-18.12%
+19.07%
+45.42%
EPS
-1.22
-0.67
+0.55
Beat Est.
+28.30%
+60.82%
+45.35%
Strong Buy

Feb 28, 2025

Ascendis Pharma A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 125.611M--
--2025/Q1-- / 93.986M--
Feb 12, 20252024/Q4173.916M / 119.596M--
Nov 14, 20242024/Q357.833M / 70.312M--
Sep 3, 20242024/Q235.998M / 84.468M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 125.611M--
--2025/Q1-- / 93.986M--
Feb 12, 20252024/Q4173.916M / 119.596M--
Nov 14, 20242024/Q357.833M / 70.312M--
Sep 3, 20242024/Q235.998M / 84.468M--

Unlock Free Earnings Estimates

Ascendis Pharma A/S Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Strong Buy

  • Buy

    92.86%
  • Hold

    7.14%
  • Sell

    0.00%

Price Target

No Data